AROMASIN is indicated for adjuvant treatment method of postmenopausal Females with estrogen-receptor good early breast cancer which have gained two to a few years of tamoxifen and are switched to AROMASIN for completion of a complete of 5 consecutive several years of adjuvant hormonal therapy [see Medical Experiments (fourteen.1)].Exemestane has an